Edition:
United Kingdom

Antares Pharma Inc (ATRS.OQ)

ATRS.OQ on NASDAQ Stock Exchange Capital Market

3.15USD
11 Dec 2018
Change (% chg)

$-0.03 (-0.94%)
Prev Close
$3.18
Open
$3.23
Day's High
$3.26
Day's Low
$3.11
Volume
110,628
Avg. Vol
295,850
52-wk High
$3.93
52-wk Low
$1.75

Select another date:

Mon, Oct 1 2018

Antares Pharma's testosterone drug gets FDA approval

The U.S. Food and Drug Administration on Monday approved Antares Pharma Inc's injectable drug to treat low testosterone levels in men, the company said, nearly a year after being rejected.

UPDATE 1-Antares Pharma's testosterone drug gets FDA approval

Oct 1 The U.S. Food and Drug Administration on Monday approved Antares Pharma Inc's injectable drug to treat low testosterone levels in men, the company said, nearly a year after being rejected.

Antares Pharma's testosterone drug gets FDA approval

Oct 1 The U.S. Food and Drug Administration on Monday approved Antares Pharma Inc's drug to treat low testosterone levels in men, the company said, nearly a year after rejecting the injection.

MEDIA-Russia to supply U.S. with new rocket engines - Kommersant

* Russian engine maker Energomash has signed a new contract to supply four RD-181 rocket engines to U.S. aerospace firm Orbital ATK by 2021 for its Antares rocket, the Kommersant newspaper wrote on Tuesday.

Select another date: